Abstract A015: Biochemical and preclinical anti-tumor activity of a bi-steric mTORC1-selective inhibitor in fusion positive rhabdomyosarcoma.

Jacqueline Morales, Kristen Kwong, W. Clay Gustafson, Amit J. Sabnis. Abstract A015: Biochemical and preclinical anti-tumor activity of a bi-steric mTORC1-selective inhibitor in fusion positive rhabdomyosarcoma. Clinical Cancer Research. 2022 Sep 15; 28(18_Supplement):a015-a015.

2022
https://researcherprofiles.org/profile/344526135

Jacqueline Morales, Kristen Kwong, W. Clay Gustafson, Amit J. Sabnis